FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sibylle Loibl

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Carsten Denkert; M Dietel; Jörn Hilfrich; T Kirchner; Ralf Kronenwett; Sibylle Loibl; Berit-Maria Müller; V Nekljudova; C Petry; C Roth; B V Sinn; C Solbach; A Staebler; Michael Untch; G Altmann; B Ataseven; Jan Budczies; S Darb-Esfahani; C von Törne; Gunter von Minckwitz
RNA-based determination of ESR1 and HER2 expression and response to neoadjuvant chemotherapy.
L C Hanker; P Harter; Sibylle Loibl; W Meier; J Pfisterer; E Pujade-Lauraine; I Ray-Coquard; Jalid Sehouli; N Burchardi; Andreas du Bois
The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane/platinum-based therapy.
Gunter von Minckwitz; Keyur Mehta; Valentina Nekljudova; Michael Untch; Jens-Uwe Blohmer; Serban-Dan Costa; Carsten Denkert; Holger Eidtmann; Wolfgang Eiermann; Peter A Fasching; Bernd Gerber; Jörn Hilfrich; Jens Huober; Christian Jackisch; Manfred Kaufmann; Gottfried E Konecny; Sibylle Loibl
Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sibylle Loibl (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Carsten Denkert; M Dietel; Jörn Hilfrich; T Kirchner; Ralf Kronenwett; Sibylle Loibl; Berit-Maria Müller; V Nekljudova; C Petry; C Roth; B V Sinn; C Solbach; A Staebler; Michael Untch; G Altmann; B Ataseven; Jan Budczies; S Darb-Esfahani; C von Törne; Gunter von Minckwitz
RNA-based determination of ESR1 and HER2 expression and response to neoadjuvant chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013;24(3):632-9.
2012: L C Hanker; P Harter; Sibylle Loibl; W Meier; J Pfisterer; E Pujade-Lauraine; I Ray-Coquard; Jalid Sehouli; N Burchardi; Andreas du Bois
The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane/platinum-based therapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(10):2605-12.
2012: Gunter von Minckwitz; Keyur Mehta; Valentina Nekljudova; Michael Untch; Jens-Uwe Blohmer; Serban-Dan Costa; Carsten Denkert; Holger Eidtmann; Wolfgang Eiermann; Peter A Fasching; Bernd Gerber; Jörn Hilfrich; Jens Huober; Christian Jackisch; Manfred Kaufmann; Gottfried E Konecny; Sibylle Loibl
Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(15):1796-804.
2012: Scarlet F Brockmöller; Elmar Bucher; Jan Budczies; Silvia Darb-Esfahani; Nikola Bangemann; Manfred Dietel; Oliver Fiehn; Julian L Griffin; Mika Hilvo; Kristiina Iljin; Fakher Ismaeel; Olli Kallioniemi; Frederick Klauschen; Sibylle Loibl; Berit-Maria Müller; Matej Oresic; Judith Prinzler; Bruno V Sinn; Carsten Denkert
Integration of metabolomics and expression of glycerol-3-phosphate acyltransferase (GPAM) in breast cancer-link to patient survival, hormone receptor status, and metabolic profiling.
Journal of proteome research 2012;11(2):850-60.
2012: Michael Untch; Gunter von Minckwitz; Joachim Bischoff; Jens-Uwe Blohmer; Holger Eidtmann; Peter A Fasching; Bernd Gerber; Claus Hanusch; Jörn Hilfrich; Jens Huober; Christian Jackisch; Manfred Kaufmann; Rolf Kreienberg; Thorsten Kühn; Sibylle Loibl; Valentina Nekljudova; Mahdi Rezai; Dirk Strumberg; Hans Tesch
Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial.
The lancet oncology 2012;13(2):135-44.
2012: Gunter von Minckwitz; Jens-Uwe Blohmer; Carsten Denkert; Holm Eggemann; Holger Eidtmann; Peter A Fasching; Tanja Fehm; Bernd Gerber; Claus Hanusch; Maik Hauschild; Jens Huober; Christian Jackisch; Kornelia Kittel; Rolf Kreienberg; Georg Kunz; Sibylle Loibl; Berit-Maria Müller; Valentina Nekljudova; Mahdi Rezai; Iris Schrader; Christine Solbach; Hans Tesch; Michael Untch
Neoadjuvant chemotherapy and bevacizumab for HER2-negative breast cancer.
The New England journal of medicine 2012;366(4):299-309.
2012: Antonia Sophie Wenners; Norbert Arnold; Beyhan Ataseven; Silvia Darb-Esfahani; Carsten Denkert; Sigrid Hamann; Hans-Juergen Holzhausen; Walter Jonat; Fariba Khandan; Sibylle Loibl; Keyur Mehta; Berit Mueller; Christoph Mundhenke; Hyerim Park; Christian Schem; Christoph Thomssen; Gunther von Minckwitz; Jörg Weimer; Maret Bauer
Neutrophil gelatinase-associated lipocalin (NGAL) predicts response to neoadjuvant chemotherapy and clinical outcome in primary human breast cancer.
PloS one 2012;7(10):e45826.
2012: Carsten Denkert; Dinesh Kumar Barupal; Scarlet Brockmöller; Elmar Bucher; Jan Budczies; Julian Griffin; Mika Hilvo; Kristiina Iljin; Frederick Klauschen; Sibylle Loibl; Valentina Nekljudova; Matej Oresic; Reza Salek; Oliver Fiehn
Metabolomics of human breast cancer: new approaches for tumor typing and biomarker discovery.
Genome medicine 2012;4(4):37.
2011: Sibylle Loibl; Keyur Mehta; Berit-Maria Müller; Marc Roller; Michael Schwabe; Gunter von Minckwitz; Jens-Uwe Alles; Beyhan Ataseven; Silvia Darb-Esfahani; Andreas du Bois; Annette Fissler-Eckhoff; Bernd Gerber; Uwe Kulmer; Carsten Denkert
Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy.
Breast cancer research and treatment 2011;130(2):477-87.
2011: Sibylle Loibl; Volker Moebus; Volkmar Mueller; Valentina Nekljudova; Gunter von Minckwitz; Bettina Conrad; Helmut Forstbauer; Claus-Henning Koehne; Stephan Kremers; Mattea Linder
Comparison of pegfilgrastim on day 2 vs. day 4 as primary prophylaxis of intense dose-dense chemotherapy in patients with node-positive primary breast cancer within the prospective, multi-center GAIN study: (GBG 33).
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2011;19(11):1789-95.
2011: Gunter von Minckwitz; Diethelm Wallwiener; Kai Budischewski; Andreas du Bois; Christian Jackisch; Sibylle Loibl; Michael P Lux; Nico Maass; Caroline Nestle-Kraemling; Stefan Paepke; Rita Schmutzler; Sabine Vescia; Manfred Kaufmann
The GISS trial: a phase II prevention trial of screening plus goserelin, ibandronate, versus screening alone in premenopausal women at increased risk of breast cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011;20(10):2141-9.
2011: K Baumann; N Burchardi; Andreas du Bois; Jens Huober; Christian Kurzeder; Sibylle Loibl; H J Lück; Jacobus Pfisterer; Barbara Schmalfeldt; Jalid Sehouli; I Vergote; Pauline Wimberger; U Wagner
Intraperitoneal treatment with the trifunctional bispecific antibody Catumaxomab in patients with platinum-resistant epithelial ovarian cancer: a phase IIa study of the AGO Study Group.
Gynecologic oncology 2011;123(1):27-32.
2011: Michael Untch; H Urbaczyk; F Von Koch; G von Minckwitz; U Conrad; P A Fasching; W Fett; N Harbeck; S Hasmüller; Gottfried E Konecny; Christian Kurzeder; A Lebeau; M Lenhard; B Liedtke; Sibylle Loibl; Hans-Joachim Lück; V Müller; V Nekljudova; C Salat; M Schmidt; T Schuster; Elmar Stickeler
PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel ± darbepoetin alfa in primary breast cancer--results at the time of surgery.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(9):1988-98.
2011: Michael Untch; H Urbaczyk; G von Minckwitz; M W Beckmann; U Conrad; P A Fasching; W Fett; N Harbeck; S Hasmüller; Gottfried E Konecny; Christian Kurzeder; A Lebeau; M Lenhard; B Liedtke; Sibylle Loibl; Hans-Joachim Lück; V Müller; V Nekljudova; C Salat; M Schmidt; Elmar Stickeler
PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin-cyclophosphamide followed by paclitaxel with or without darbepoetin alfa in primary breast cancer--outcome on prognosis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(9):1999-2006.
2011: Gunter von Minckwitz; Berit-Maria Müller; Sibylle Loibl; Jan Budczies; Claus Hanusch; Silvia Darb-Esfahani; Jörn Hilfrich; Erich Weiss; Jens Huober; Jens-Uwe Blohmer; Andreas du Bois; Dirk-Michael Zahm; Fariba Khandan; Gerald Hoffmann; Bernd Gerber; Holger Eidtmann; Falko Fend; Manfred Dietel; Keyur Mehta; Carsten Denkert
Cytoplasmic poly(adenosine diphosphate-ribose) polymerase expression is predictive and prognostic in patients with breast cancer treated with neoadjuvant chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(16):2150-7.
2011: Mika Hilvo; Tuulia Hyötyläinen; Kristiina Iljin; Olli Kallioniemi; Laura Lehtinen; Sibylle Loibl; Berit Müller; Heli Nygren; Emilia Berg; Scarlet Brockmöller; Elmar Bucher; Jan Budczies; Sandra Castillo; Carsten Denkert; Oliver Fiehn; Julian L Griffin; Cornelia Radke; Christiane Richter-Ehrenstein; Tuulikki Seppänen-Laakso; Marko Sysi-Aho; Laxman Yetukuri; Matej Oresic
Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression.
Cancer research 2011;71(9):3236-45.
2011: Aurelia Noske; Sibylle Loibl; S Darb-Esfahani; M Roller; Ralf Kronenwett; Berit-Maria Müller; J Steffen; C von Toerne; R Wirtz; I Baumann; G Hoffmann; G Heinrich; S T Grasshoff; H U Ulmer; Carsten Denkert; Gunter von Minckwitz
Comparison of different approaches for assessment of HER2 expression on protein and mRNA level: prediction of chemotherapy response in the neoadjuvant GeparTrio trial (NCT00544765).
Breast cancer research and treatment 2011;126(1):109-17.
2011: G von Minckwitz; H Eidtmann; Sibylle Loibl; J-U Blohmer; S-D Costa; P A Fasching; R Kreienberg; J Hilfrich; B Gerber; C Hanusch; T Fehm; D Strumberg; C Solbach; V Nekljudova; M Untch
Integrating bevacizumab, everolimus, and lapatinib into current neoadjuvant chemotherapy regimen for primary breast cancer. Safety results of the GeparQuinto trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(2):301-6.
2011: Sibylle Loibl; Tomas Skacel; Valentina Nekljudova; Hans Joachim Lück; Matthias Schwenkglenks; Thomas Brodowicz; Christoph Zielinski; Gunter von Minckwitz
Evaluating the impact of Relative Total Dose Intensity (RTDI) on patients' short and long-term outcome in taxane- and anthracycline-based chemotherapy of metastatic breast cancer- a pooled analysis.
BMC cancer 2011;11():131.
2010: Andreas du Bois; Jens Huober; P Stopfer; Jacobus Pfisterer; Pauline Wimberger; Sibylle Loibl; V L Reichardt; Philipp Harter
A phase I open-label dose-escalation study of oral BIBF 1120 combined with standard paclitaxel and carboplatin in patients with advanced gynecological malignancies.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(2):370-5.
2009: Philipp Harter; M Hahmann; Hans-Joachim Lueck; M Poelcher; Pauline Wimberger; O Ortmann; U Canzler; Barbara Richter; Uwe Wagner; A Hasenburg; Alexander Burges; Sibylle Loibl; Werner Meier; Jens Huober; D Fink; Willibald Schroeder; K Muenstedt; Barbara Schmalfeldt; G Emons; Andreas du Bois
Surgery for recurrent ovarian cancer: role of peritoneal carcinomatosis: exploratory analysis of the DESKTOP I Trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis.
Annals of surgical oncology 2009;16(5):1324-30.
2009: Knut Engels; Andreas du Bois; P Harter; Annette Fisseler-Eckhoff; Friedrich Kommoss; Roland H Stauber; Manfred Kaufmann; V Nekljudova; Sibylle Loibl
VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection.
Journal of clinical pathology 2009;62(5):448-54.
2009: Gunter von Minckwitz; Andreas du Bois; Marcus Schmidt; Nicolai Maass; Tanja Cufer; Felix E de Jongh; Eduard Maartense; Christoph Zielinski; Manfred Kaufmann; Wolfgang Bauer; Klaus H Baumann; Michael R Clemens; Ralph Duerr; Christoph Uleer; Michael Andersson; Robert C Stein; Valentina Nekljudova; Sibylle Loibl
Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a german breast group 26/breast international group 03-05 study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(12):1999-2006.
2009: Sibylle Loibl; Caroline Murmann; Katrin Schwedler; Mathias Warm; Lothar Müller; Georg Heinrich; Valentina Nekljudova; Gunter von Minckwitz
Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: RiTa trial.
Cancer chemotherapy and pharmacology 2009;63(5):953-8.
2009: Nancy U Lin; Véronique Diéras; Devchand Paul; Dominique Lossignol; Christos Christodoulou; Hans-Joachim Stemmler; Henri Roché; Minetta C Liu; richard greil; Eva Ciruelos; Sibylle Loibl; Stefania Gori; Andrew Wardley; Denise Yardley; Adam Brufsky; Joanne L Blum; Stephen D Rubin; Bernie Dharan; Klaudia Steplewski; Denise Zembryki; Cristina Oliva; Debasish Roychowdhury; Paolo Paoletti; Eric P Winer
Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(4):1452-9.
2008: Knut Engels; Shirley K Knauer; Sibylle Loibl; Verena Fetz; Philipp Harter; Andrea Schweitzer; Annette Fisseler-Eckhoff; Friedrich Kommoss; Lars Hanker; Valentina Nekljudova; Iris Hermanns; Hartmut Kleinert; Wolf Mann; Andreas du Bois; Roland H Stauber
NO signaling confers cytoprotectivity through the survivin network in ovarian carcinomas.
Cancer research 2008;68(13):5159-66.
2008: Gunter von Minckwitz; Sherko Kümmel; Petra Vogel; Claus Hanusch; Holger Eidtmann; Jörn Hilfrich; Bernd Gerber; Jens Huober; Serban-Dan Costa; Christian Jackisch; Sibylle Loibl; Keyur Mehta; Manfred Kaufmann
Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial.
Journal of the National Cancer Institute 2008;100(8):542-51.
2008: Gunter von Minckwitz; Sherko Kümmel; Petra Vogel; Claus Hanusch; Holger Eidtmann; Jörn Hilfrich; Bernd Gerber; Jens Huober; Serban-Dan Costa; Christian Jackisch; Sibylle Loibl; Keyur Mehta; Manfred Kaufmann
Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio study.
Journal of the National Cancer Institute 2008;100(8):552-62.
2008: Gunter von Minckwitz; S Kümmel; Andreas du Bois; Wolfgang Eiermann; Holger Eidtmann; Bernd Gerber; Jörn Hilfrich; Jens Huober; Serban-Dan Costa; Christian Jackisch; S-T Grasshoff; Sabine Vescia; T Skacel; Sibylle Loibl; K M Mehta; Manfred Kaufmann
Pegfilgrastim +/- ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(2):292-8.
2008: Sibylle Loibl; Gunter von Minckwitz; Nadia Harbeck; Wolfgang Janni; Dirk Elling; Manfred Kaufmann; Holm Eggemann; Valentina Nekljudova; Harald Sommer; Marion Kiechle; Sherko Kümmel
Clinical feasibility of (neo)adjuvant taxane-based chemotherapy in older patients: analysis of >4,500 patients from four German randomized breast cancer trials.
Breast cancer research : BCR 2008;10(5):R77.
2008: Gunter von Minckwitz; Hans-Peter Sinn; Günter Raab; Sibylle Loibl; Jens-Uwe Blohmer; Holger Eidtmann; Jörn Hilfrich; Elisabeth Merkle; Christian Jackisch; Serban D Costa; Angelika Caputo; Manfred Kaufmann
Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast.
Breast cancer research : BCR 2008;10(2):R30.
2008: Sabine Vescia; A K Baumgärtner; V R Jacobs; Marion Kiechle-Bahat; Achim Rody; Sibylle Loibl; N Harbeck
Management of venous port systems in oncology: a review of current evidence.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(1):9-15.
2007: Manfred Kaufmann; Gunter von Minckwitz; H D Bear; A Buzdar; P McGale; H Bonnefoi; M Colleoni; C Denkert; Wolfgang Eiermann; R Jackesz; Andreas Makris; W Miller; J-Y Pierga; Vladimir Semiglazov; Andreas Schneeweiss; Rainer Souchon; Vered Stearns; Michael Untch; Sibylle Loibl
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(12):1927-34.
2007: Andreas du Bois; Jacobus Pfisterer; N Burchardi; Sibylle Loibl; Jens Huober; Pauline Wimberger; Alexander Burges; Anne Stähle; Christian Jackisch; H Kölbl
Combination therapy with pegylated liposomal doxorubicin and carboplatin in gynecologic malignancies: a prospective phase II study of the Arbeitsgemeinschaft Gynäekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and Kommission Uterus (AGO-K-Ut).
Gynecologic oncology 2007;107(3):518-25.
2007: Manfred Kaufmann; Erika Graf; Walter Jonat; Wolfgang Eiermann; Sabine Vescia; Matthias Geberth; Bettina Conrad; Günther Gademann; Ute-Susann Albert; Sibylle Loibl; Gunter von Minckwitz; Martin Schumacher
A randomised trial of goserelin versus control after adjuvant, risk-adapted chemotherapy in premenopausal patients with primary breast cancer - GABG-IV B-93.
European journal of cancer (Oxford, England : 1990) 2007;43(16):2351-8.
2007: Achim Rody; Thomas Karn; Christine Solbach; Regine Gaetje; M Munnes; Stefan Kissler; Eugen Ruckhäberle; G V Minckwitz; Sibylle Loibl; Uwe Holtrich; Manfred Kaufmann
The erbB2+ cluster of the intrinsic gene set predicts tumor response of breast cancer patients receiving neoadjuvant chemotherapy with docetaxel, doxorubicin and cyclophosphamide within the GEPARTRIO trial.
Breast (Edinburgh, Scotland) 2007;16(3):235-40.
2007: Sibylle Loibl; K Schwedler; Gunter von Minckwitz; R Strohmeier; K M Mehta; Manfred Kaufmann
Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients--a double-blind, randomized study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(4):689-93.
2007: Uwe Wagner; Andreas du Bois; Jacobus Pfisterer; Jens Huober; Sibylle Loibl; Hans-Joachim Lück; Jalid Sehouli; Martina Gropp; Anne Stähle; Barbara Schmalfeldt; Werner Meier; Christian Jackisch
Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum-taxane based therapy--a phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6).
Gynecologic oncology 2007;105(1):132-7.
2007: Achim Rody; Uwe Holtrich; Regine Gaetje; Mathias Gehrmann; Knut Engels; Gunter von Minckwitz; Sibylle Loibl; Raihanatou Diallo-Danebrock; Eugen Ruckhäberle; Dirk Metzler; Andre Ahr; Christine Solbach; Thomas Karn; Manfred Kaufmann
Poor outcome in estrogen receptor-positive breast cancers predicted by loss of plexin B1.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(4):1115-22.
2007: Felix Hilpert; Andreas du Bois; Elfriede Greimel; J Hedderich; G Krause; L Venhoff; Sibylle Loibl; Jacobus Pfisterer
Feasibility, toxicity and quality of life of first-line chemotherapy with platinum/paclitaxel in elderly patients aged >or=70 years with advanced ovarian cancer--a study by the AGO OVAR Germany.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(2):282-7.
2007: Achim Rody; Thomas Karn; R Gätje; Andre Ahr; Christine Solbach; Katherina Kourtis; M Munnes; Sibylle Loibl; Stefan Kissler; Eugen Ruckhäberle; Uwe Holtrich; Gunter von Minckwitz; Manfred Kaufmann
Gene expression profiling of breast cancer patients treated with docetaxel, doxorubicin, and cyclophosphamide within the GEPARTRIO trial: HER-2, but not topoisomerase II alpha and microtubule-associated protein tau, is highly predictive of tumor response.
Breast (Edinburgh, Scotland) 2007;16(1):86-93.
2006: Sibylle Loibl; A Königs; Manfred Kaufmann; Serban-Dan Costa; J Bischoff
[PTHrP and bone sialoprotein as prognostic markers for developing bone metastases in breast cancer patients].
Zentralblatt für Gynäkologie 2006;128(6):330-5.
2006: Philipp Harter; Andreas du Bois; Maik Hahmann; Annette Hasenburg; Alexander Burges; Sibylle Loibl; Martina Gropp; Jens Huober; Daniel Fink; Willibald Schröder; Karsten Muenstedt; Barbara Schmalfeldt; Guenter Emons; Jacobus Pfisterer; Kerstin Wollschlaeger; Hans-Gerd Meerpohl; Georg-Peter Breitbach; Berno Tanner; Jalid Sehouli
Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial.
Annals of surgical oncology 2006;13(12):1702-10.
2006: Sibylle Loibl; Gunter von Minckwitz; Günther Raab; Jens-Uwe Blohmer; Serban Dan Costa; Bernd Gerber; Holger Eidtmann; Simone Petrich; Jörn Hilfrich; Christian Jackisch; Andreas du Bois; Manfred Kaufmann
Surgical procedures after neoadjuvant chemotherapy in operable breast cancer: results of the GEPARDUO trial.
Annals of surgical oncology 2006;13(11):1434-42.
2006: Jacobus Pfisterer; Andreas du Bois; Jalid Sehouli; Sibylle Loibl; S Reinartz; Alexander Reuss; U Canzler; A Belau; Christian Jackisch; Rainer Kimmig; Kerstin Wollschlaeger; Volker Heilmann; Felix Hilpert
The anti-idiotypic antibody abagovomab in patients with recurrent ovarian cancer. A phase I trial of the AGO-OVAR.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(10):1568-77.
2006: Achim Rody; Sibylle Loibl; Manfred Kaufmann
[Molecular diagnostic and targeted therapy--"Barking dogs are going to bite": presentations from the 42nd Annual Meeting of the American Society of Clinical Oncology, Atlanta 2006].
Zentralblatt für Gynäkologie 2006;128(5):233-41.
2006: Manfred Kaufmann; Gabriel N Hortobagyi; Aron Goldhirsch; Suzy Scholl; Andreas Makris; Pinuccia Valagussa; Jens-Uwe Blohmer; Wolfgang Eiermann; Raimund Jackesz; Walter Jonat; Annette Lebeau; Sibylle Loibl; William Miller; Sigfried Seeber; Vladimir Semiglazov; Roy Smith; Rainer Souchon; Vered Stearns; Michael Untch; Gunter von Minckwitz
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(12):1940-9.
2006: Achim Rody; Thomas Karn; R Gätje; Katherina Kourtis; G Minckwitz; Sibylle Loibl; M Munnes; Eugen Ruckhäberle; Uwe Holtrich; Manfred Kaufmann; Andre Ahr
Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
Zentralblatt für Gynäkologie 2006;128(2):76-81.
2006: Sibylle Loibl; Gunter von Minckwitz; Karin Gwyn; Paul Ellis; Jens-Uwe Blohmer; Brigitte Schlegelberger; Monika Keller; Sebastian Harder; Richard L Theriault; Diana Crivellari; Thomas Klingebiel; Frank Louwen; Manfred Kaufmann
Breast carcinoma during pregnancy. International recommendations from an expert meeting.
Cancer 2006;106(2):237-46.
2006: Sibylle Loibl; Manfred Kaufmann; Vidya Maataoui; Keyur M Mehta; Katharina Hofmann; Simone Petrich; Gunter von Minckwitz
Darbepoetin alfa as primary prophylaxis of anemia in patients with breast cancer treated preoperatively with docetaxel/doxorubicin/cyclophosphamide.
Supportive cancer therapy 2006;3(2):103-9.
2006: Sibylle Loibl; Jutta Bratengeier; Vincent Farines; Gunter von Minckwitz; Birgit Spänkuch; Valérie B Schini-Kerth; Françoise Nepveu; Klaus Strebhardt; Manfred Kaufmann
Investigations on the inducible and endothelial nitric oxide synthases in human breast cancer cell line MCF-7 - estrogen has an influence on e-NOS, but not on i-NOS.
Pathology, research and practice 2006;202(1):1-7.
2005: Achim Rody; G V Minckwitz; Sibylle Loibl; Manfred Kaufmann
[Diagnosis and therapy of breast cancer--meeting highlights ASCO 2005].
Zentralblatt für Gynäkologie 2005;127(6):389-94.
2005: Jacobus Pfisterer; Philipp Harter; U Canzler; Barbara Richter; Christian Jackisch; M Hahmann; Annette Hasenburg; Alexander Burges; Sibylle Loibl; Martina Gropp; Jens Huober; D Fink; Andreas du Bois
The role of surgery in recurrent ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2005;15 Suppl 3():195-8.
2005: Gunter von Minckwitz; I Chernozemsky; L Sirakova; P Chilingirov; Rainer Souchon; N Marschner; U Kleeberg; C Tsekov; D Fritze; C Thomssen; N Stuart; J B Vermorken; Sibylle Loibl; Kh Merkle; M Kaufmann
Bendamustine prolongs progression-free survival in metastatic breast cancer (MBC): a phase III prospective, randomized, multicenter trial of bendamustine hydrochloride, methotrexate and 5-fluorouracil (BMF) versus cyclophosphamide, methotrexate and 5-fluorouracil (CMF) as first-line treatment of MBC.
Anti-cancer drugs 2005;16(8):871-7.
2005: Achim Rody; Sibylle Loibl; Gunter von Minckwitz; Manfred Kaufmann
Use of goserelin in the treatment of breast cancer.
Expert review of anticancer therapy 2005;5(4):591-604.
2005: Sibylle Loibl; Cornelia Strank; Gunter von Minckwitz; Hans-Peter Sinn; A Buck; Christine Solbach; Klaus Strebhardt; Manfred Kaufmann
Immunohistochemical evaluation of endothelial nitric oxide synthase expression in primary breast cancer.
Breast (Edinburgh, Scotland) 2005;14(3):230-5.
2005: Sibylle Loibl; Joachim Kohl; Manfred Kaufmann
[Reproduction after breast cancer: what advice do we have for our patients?].
Zentralblatt für Gynäkologie 2005;127(3):120-4.
2005: Achim Rody; G V Minckwitz; Sibylle Loibl; Manfred Kaufmann
[San Antonio Breast Cancer Symposium -- highlights 2004].
Zentralblatt für Gynäkologie 2005;127(2):59-65.
2005: Gunter von Minckwitz; Sebastian Harder; Sascha Hövelmann; Elke Jäger; Salah-Eddin Al-Batran; Sibylle Loibl; Akin Atmaca; Christian Cimpoiasu; Antje Neumann; Aklil Abera; Alexander Knuth; Manfred Kaufmann; Dirk Jäger; Alexander B Maurer; Winfried S Wels
Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas.
Breast cancer research : BCR 2005;7(5):R617-26.
2005: Sibylle Loibl; Angela Buck; Cornelia Strank; Gunter von Minckwitz; Marc Roller; Hans-Peter Sinn; Valérie B Schini-Kerth; Christine Solbach; Klaus Strebhardt; Manfred Kaufmann
The role of early expression of inducible nitric oxide synthase in human breast cancer.
European journal of cancer (Oxford, England : 1990) 2005;41(2):265-71.
2004: Timo Faltus; Juping Yuan; Brigitte Zimmer; Andrea Krämer; Sibylle Loibl; Manfred Kaufmann; Klaus Strebhardt
Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells.
Neoplasia (New York, N.Y.) 2004;6(6):786-95.
2004: Sibylle Loibl; Gunter von Minckwitz; K Schwedler; K A Schmidt; D Höper; M Kaufmann; Serban-Dan Costa
Mitomycin C, 5-fluorouracil and folinic acid (Mi-Fu-Fo) as salvage chemotherapy in breast cancer patients with liver metastases and impaired hepatic function: a phase II study.
Anti-cancer drugs 2004;15(7):719-24.
2003: Peter C Thuss-Patience; Gunter von Minckwitz; Albrecht Kretzschmar; Sibylle Loibl; Gerhard Schaller; Bernd Dörken; Peter Reichardt
Oxaliplatin and 5-fluorouracil for heavily pretreated metastatic breast cancer: a preliminary phase II study.
Anti-cancer drugs 2003;14(7):549-53.
2003: Christine Solbach; Marc Roller; Kai Budischewski; Sibylle Loibl; Maria Nicoletti; Manfred Stegmueller; Manfred Kaufmann
EGF-R and Her2/neu overexpressing tumors: independent collectives for treatment of breast cancer by specific monoclonal antibody-therapy.
Journal of cancer research and clinical oncology 2003;129(4):250-1.
2003: Regine Gaetje; Sibylle Loibl; B Prieshof; Manfred Kaufmann
[Uterine rupture after uterine perforation during D & C and diagnostic hysteroscopy in a patient with endometrial polyp].
Zentralblatt für Gynäkologie 2003;125(1):30-1.
2002: Gunter von Minckwitz; Sibylle Loibl; Klaus Brunnert; R Kreienberg; F Melchert; R Mösch; M Neises; J Schermann; R Seufert; R Stiglmayer; U Stosiek; Manfred Kaufmann
Adjuvant endocrine treatment with medroxyprogesterone acetate or tamoxifen in stage I and II endometrial cancer--a multicentre, open, controlled, prospectively randomised trial.
European journal of cancer (Oxford, England : 1990) 2002;38(17):2265-71.
2002: Christine Solbach; Marc Roller; Andre Ahr; Sibylle Loibl; Maria Nicoletti; Manfred Stegmueller; Hans-Georg Kreysch; Rainald Knecht; Manfred Kaufmann
Anti-epidermal growth factor receptor-antibody therapy for treatment of breast cancer.
International journal of cancer. Journal international du cancer 2002;101(4):390-4.
2002: Sibylle Loibl; Gunter von Minckwitz; Sonja Weber; Hans-Peter Sinn; Valérie B Schini-Kerth; Irina Lobysheva; Françoise Nepveu; Georg Wolf; Klaus Strebhardt; Manfred Kaufmann
Expression of endothelial and inducible nitric oxide synthase in benign and malignant lesions of the breast and measurement of nitric oxide using electron paramagnetic resonance spectroscopy.
Cancer 2002;95(6):1191-8.
2002: Birgit Spänkuch; Georg Wolf; Christine Solbach; Sibylle Loibl; Rainald Knecht; Manfred Stegmüller; Gunter von Minckwitz; Manfred Kaufmann; Klaus Strebhardt
Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells.
Oncogene 2002;21(20):3162-71.
2000: G von Minckwitz; E M Grischke; S Schwab; S Hettinger; Sibylle Loibl; M Aulmann; Manfred Kaufmann
Predictive value of serum interleukin-6 and -8 levels in preterm labor or rupture of the membranes.
Acta obstetricia et gynecologica Scandinavica 2000;79(8):667-72.